Skip to main navigation Skip to search Skip to main content

A novel class of highly potent multidrug resistance reversal agents: Disubstituted adamantyl derivatives

  • Kyung Hoon Min
  • , Yan Xia
  • , Eun Kyung Kim
  • , Yinglan Jin
  • , Navneet Kaur
  • , Eun Seon Kim
  • , Dae Kyong Kim
  • , Hwa Young Jung
  • , Yongseok Choi
  • , Mi Kyung Park
  • , Yong Ki Min
  • , Kiho Lee
  • , Kyeong Lee

Research output: Contribution to journalArticlepeer-review

15 Scopus citations

Abstract

Novel disubstituted adamantyl derivatives were synthesized and evaluated in a P-glycoprotein dependent multidrug resistance cancer cell line. The hit to lead optimization provided potent MDR reversal agents. Some potent adamantyl derivatives were more than 10-fold more potent than verapamil without considerable intrinsic cytotoxicity. The 3-trifluorophenyl derivative 14f did not affect the metabolism of CYP450 3A4, whereas most of MDR revertants had a weak inhibitory effect.

Original languageEnglish
Pages (from-to)5376-5379
Number of pages4
JournalBioorganic and Medicinal Chemistry Letters
Volume19
Issue number18
DOIs
StatePublished - 15 Sep 2009

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • ABC transporter
  • Adamantane
  • CYP3A4
  • MES-SA/DX5
  • Multidrug resistance
  • P-glycoprotein

Fingerprint

Dive into the research topics of 'A novel class of highly potent multidrug resistance reversal agents: Disubstituted adamantyl derivatives'. Together they form a unique fingerprint.

Cite this